NCT05698459View on ClinicalTrials.gov

OH2 Oncolytic Viral Therapy Via Transcatheter Intraarterial Infusion in Patients with Advanced Liver Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

May 5, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

January 31, 2026

Conditions
Advanced Liver Cancer
Interventions
BIOLOGICAL

OH2 injection

OH2 injection administered by transcatheter Intraarterial infusion

Trial Locations (1)

430000

RECRUITING

Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology, Wuhan

Sponsors
All Listed Sponsors
lead

Binhui Biopharmaceutical Co., Ltd.

INDUSTRY